Concordia International (CXRX) Under Heavy Pressure Amid Proposed UK Drug Price Bill

September 16, 2016 9:37 AM EDT

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Concordia International (NASDAQ: CXRX) slammed which is attributed to a new proposed UK bill to control drug prices. Shares down 13.8%.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Trader Talk

Add Your Comment